NEW YORK , Oct. 23, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The Global Human Platelet Lysate Market size is estimated to grow by USD 0.011 million from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 3.64% during the forecast period. Rising prevalence of chronic diseases is driving market growth, with a trend towards growing investments in stem cell research.
However, stringent regulations and quality control requirements for human-derived products poses a challenge - Key market players include Amerigo Scientific, AventaCell BioMedical Corp. Ltd., BioLife Solutions Inc.
, Compass Biomedical Inc., Creative Biolabs, GeminiBio, Macopharma SA, Merck KGaA, Mill Creek Life Sciences Inc., MP Biomedicals Inc.
, PAN-Biotech GmbH, PL BioScience GmbH, Regenexx Des Moines, Sartorius AG, Sartorius CellGenix GmbH, Serana Europe GmbH, STEMCELL Technologies Inc., TCS Biosciences Ltd., TRINOVA BIOCHEM GmbH, and ZenBio Inc.
. Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View the snapshot of this report Market Driver The human platelet lysate market is experiencing significant growth due to increasing investments in stem cell research.
Stem cells, with their potential to treat various diseases, necessitate high-quality cell culture supplements for growth and differentiation. Human platelet lysate, abundant in growth factors and cytokines, is a preferred choice in this .